| 1 |
How does the concept of “model as a dataset” reshape traditional data-sharing practices in medical imaging?
|
3. It enables sharing of learned model weights instead of sensitive raw images. |
|
Instead of using and sharing real patient images, model as a dataset shares synthetic and training model weights to protect privacy but also allow collaboration. |
The generative ai creates synthetic images similar to original images without revealing private information which allows collaboration to happen. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which analytical conclusion can be drawn about the trade-offs between physics-informed and statistical models?
|
2. Physics-informed models are more interpretable but computationally intensive. |
|
Physics-informed models use known physical laws and predictions are easier to interpret but require heavy computing. |
Evidence in article about physics-informed models. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
Why is “mode collapse” considered a critical problem in GAN-based medical image synthesis?
|
4. It ensures ethical compliance. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Why are healthcare-specific metrics preferred over general-purpose metrics such as FID or SSIM?
|
3. They depend on ImageNet-trained features. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What does the article identify as the key tension between privacy preservation and image fidelity?
|
1. Higher realism may risk reproducing identifiable patient data. |
|
Synthetic images get increasingly more realistic which comes with a risk of revealing private patient information |
More realistic means more closer to original |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
Why is the FDA’s approval of synthetic MRI technology significant for future AI-generated data?
|
1. It establishes a framework for validating synthetic data equivalence in clinical use. |
|
FDA approved that synthetic MRI can be assessed for safety and its effectiveness similar to real data. |
FDA approval could pave the way for ai generated medical images. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
Which strategy would best mitigate demographic bias in generative models according to the article?
|
2. Applying diversity-aware training and fairness constraints |
|
Fairness reduces bias in models |
Fairness reduces bias in models |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
How do DDPMs exemplify versatility in healthcare image synthesis?
|
2. They can perform multiple tasks such as denoising, inpainting, and anomaly detection without retraining. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
What analytical insight does the article provide about integrating AI-generated medical images into education and research?
|
2. It enhances training by providing diverse, realistic datasets without ethical breaches. |
|
Synthetic images allow students and researchers practice on realistic cases with patient privacy |
Synthetic images are fake but similar to real medical images so students can practice without revealing patient data |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
Why is regional calibration essential when applying risk prediction models across countries?
|
2. To adjust for population-specific incidence and lifestyle differences |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What analytical conclusion can be drawn when comparing the China-PAR and Framingham models?
|
2. China-PAR uses local epidemiological data, leading to improved predictive validity. |
|
China-PAR uses local data, lifestyle and diet which is more accurate |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Based on CVD mortality data, what analytical inference can be made about Japan’s position compared to neighboring countries?
|
1. Japan’s low CVD mortality suggests effective prevention and healthcare systems. |
|
Compared to other east asian countries, japan shows lower cvd mortality, which illustrates that public health measures and medical management is effective. |
Japan has lower CVD mortality means its healthier |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What analytical limitation arises when using Western-derived coefficients in East Asian models?
|
2. It introduces systematic overestimation of ASCVD probability. |
|
East asians and westerner data is different, implementing western models will overestimate ASCVD risk in east asia |
Western and east asian data is different. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What policy implication can be derived from country-specific risk models?
|
2. They discourage data sharing. |
|
Data is different for every country |
Data is different for every country |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
If a model excludes socioeconomic variables, what analytical consequence might occur?
|
4. Reduced data bias |
|
Less data is used |
Less data used |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
How might AI improve next-generation ASCVD risk prediction in East Asia?
|
2. By integrating multimodal data, including imaging and lifestyle information |
|
Ai could combine these datas to improve accuracy for east asians |
Ai could combine these datas to improve accuracy for east asians |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What conclusion can be drawn from comparing Mongolia’s and South Korea’s CVD mortality rates?
|
2. Both have identical age-adjusted mortality rates. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What is the most logical future direction for improving ASCVD models across East Asia?
|
1. Establishing multinational data-sharing platforms to harmonize regional models |
|
To improve accuracy |
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
According to the “image generation trilemma” shown in the figure, what analytical conclusion can be drawn about the relative strengths of VAEs, GANs, and DDPMs in medical image synthesis?
|
2. GANs provide a balance between image quality and diversity but may suffer from mode collapse. |
|
|
|
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
Based on Figure, what analytical conclusion can be drawn regarding the distribution of cardiovascular disease (CVD) subtypes across East Asian countries?
|
2. Stroke dominates as the primary cause of CVD death in all East Asian countries equally. |
|
Data shows stroke as highest cause of CVD death average percentage at 44.5 |
Data shows stroke as highest cause of CVD death average percentage at 44.5 |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|